Ovarian Cancer Early Detection by Circulating CA125 in the context of Anti-CA125 Autoantibody Levels: Results from the EPIC cohort

CA125 is the best ovarian cancer early detection marker to date; however, sensitivity is limited and complementary markers are required to improve discrimination between ovarian cancer cases and non-cases. Anti-CA125 autoantibodies are observed in circulation. Our objective was to evaluate whether t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Cancer
Main Authors: Fortner, Renée T., Schock, Helena, Le Cornet, Charlotte, Hüsing, Anika, Vitonis, Allison F., Johnson, Theron S., Fichorova, Raina N., Fashemi, Titilayo, Yamamoto, Hidemi S., Tjønneland, Anne, Hansen, Louise, Overvad, Kim, Boutron-Ruault, Marie-Christine, Kvaskoff, Marina, Severi, Gianluca, Boeing, Heiner, Trichopoulou, Antonia, Papatesta, Eleni-Maria, Vecchia, Carlo La, Palli, Domenico, Sieri, Sabina, Tumino, Rosario, Sacerdote, Carlotta, Mattiello, Amalia, Onland-Moret, N. Charlotte, Peeters, Petra H., Bueno-de-Mesquita, H.B(as)., Weiderpass, Elisabete, Quirós, J. Ramón, Duell, Eric J, Sánchez, Maria-Jose, Navarro, Carmen, Ardanaz, Eva, Larrañaga, Nerea, Nodin, Björn, Jirström, Karin, Idahl, Annika, Lundin, Eva, Khaw, Kay-Tee, Travis, Ruth C., Gunter, Marc, Johansson, Mattias, Dossus, Laure, Merritt, Melissa A., Riboli, Elio, Terry, Kathryn L., Cramer, Daniel W., Kaaks, Rudolf
פורמט: Artigo
שפה:Inglês
יצא לאור: 2017
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805613/
https://ncbi.nlm.nih.gov/pubmed/29159934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31164
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים